Lanzhou Foci Pharmaceutical Co (SZSE:002644) ROCE % : 0.86% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Lanzhou Foci Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 0.86%.

Lanzhou Foci Pharmaceutical Co ROCE % Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co ROCE % Chart

Lanzhou Foci Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

4.06

6.79

5.67

6.50

4.02

Lanzhou Foci Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															1.30	1.01	6.43	1.75	0.86

Lanzhou Foci Pharmaceutical Co ROCE % Calculation

Lanzhou Foci Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	82.883	/	( ( (2606.429 - 542.542)	+	(2528.102 - 467.688) )	/ 2 )
	=	82.883	/	( (2063.887	+	2060.414)	/ 2 )
	=	82.883	/	2062.1505
	=	4.02 %

Lanzhou Foci Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	17.752	/	( ( (2484.421 - 419.664)	+	(2471.585 - 409.207) )	/ 2 )
	=	17.752	/	( ( 2064.757	+	2062.378 )	/ 2 )
	=	17.752	/	2063.5675
	=	0.86 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Lanzhou Foci Pharmaceutical Co (SZSE:002644) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Lanzhou Foci Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Lanzhou Foci Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lanzhou Foci Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046

Website

http://www.fczy.com

Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australia, Russia, and Ukraine, among others.

Executives

Sun Yu	Directors, executives
Su Wen Bo	Supervisors
An Wen Ting	Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines